Results 61 to 70 of about 5,044 (233)

Midodrine: a role in the management of neurocardiogenic syncope [PDF]

Heart, 1998
To determine the benefit of midodrine, an alpha agonist, on symptom frequency and haemodynamic responses during head up tilt in patients with neurocardiogenic syncope.Cardiovascular investigation unit (a secondary and tertiary referral centre for the investigation and management of syncope).16 outpatients (mean (SD) age 56 (18) years; five men) with ...
J J Gilroy, Rose Anne Kenny, J C Gray, C R Ward   +3 more
openaire   +3 more sources

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies

Alimentary Pharmacology &Therapeutics, EarlyView.
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj, Paul Kwo, Stephen Chris Pappas, Jacqueline G. O'Leary, Khurram Jamil, Sanaz Cardoza, Florence Wong   +6 more
wiley   +1 more source

Exploring the Efficacy of Midodrine for Tapering Off Vasopressors

Cureus
Sepsis and septic shock represent critical conditions, often necessitating vasopressor support in the intensive care unit (ICU). Midodrine, an oral vasopressor, has gathered attention as a potential adjunct to vasopressor therapy, aiming to facilitate ...
Z. M. Athar, Mahnoor Arshad, Shitij Shrivastava   +2 more
semanticscholar   +1 more source

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research

British Journal of Clinical Pharmacology, EarlyView.
Aerospace medicine required controlled terrestrial models to investigate influences of altered atmosphere conditions, such as hypoxia, on human health and performance. These models could potentially be expanded to encompass disease conditions or treatment targets regulated through hypoxia or hypercapnia.
Titiaan E. Post, Cayla Denney, Adam Cohen, Jens Jordan, Ulrich Limper   +4 more
wiley   +1 more source

Clinical management of neurogenic orthostatic hypotension

Annals of Movement Disorders, 2019
Neurogenic orthostatic hypotension is a common disorder often seen in elderly patients affected with neurodegenerative disorders and peripheral neuropathies.
Malligurki Raghurama Rukmani, Ravi Yadav, Pramod K Pal, Talakad N Sathyaprabha   +3 more
doaj   +1 more source

Impact of Midodrine on Optimization of β-blocker Therapy in Patients with Heart Failure with Reduced Ejection Fraction

Nursing & Health Sciences Research Journal, 2023
Introduction: Midodrine, an α -adrenergic agonist approved for orthostatic hypotension, is used off-label for hypotension in patients with heart failure with reduced ejection fraction (HFrEF).
Maria A. Ruiz, Dayana Martinez, Maura Falli, Kristen de Almeida, Radhan B. Gopalani   +4 more
semanticscholar   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Anti-hypotensive effect of “Yahom Navakot” in rats with orthostatic hypotension

Journal of Traditional and Complementary Medicine, 2022
Background and aim: Yahom Navakot (YN), is a Thai traditional medicine, consisting of 54 plants, for treating fainting and dizziness. Thus, YN might relieve orthostatic hypotension (OH) symptoms, but its therapeutic action is unclear.
Anjaree Inchan, Thanika Pathomwichaiwat, Tippaporn Bualeong, Sasipong Tipratchadaporn, Krongkarn Chootip   +4 more
doaj   +1 more source

Oral Midodrine Use in Weaning of Intravenous Vasopressor Infusions in Septic Shock Patients

Benha Journal of Applied Sciences
Background: Sepsis is characterized as an infection that causes potentially fatal organ malfunction as a result of a dysregulated patient response to the infection (SSC), with septic shock being a subgroup of sepsis linked with greater fatality rates due
Muhammed A.Elmorsy, Saad I.Saad, Mariam M.S.El. Wahdan   +2 more
semanticscholar   +1 more source

Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?

Cleveland Clinic journal of medicine, 2023
Research and robust data are still lacking regarding use of midodrine in this setting.
Simran Gupta, Ayan Sen, Aman Verma
semanticscholar   +1 more source